title: Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.
authors.affiliation: Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. syoon@partners.org
authors.forename: Sam S
authors.initials: SS
authors.lastname: Yoon
authors.forename: Dan G
authors.initials: DG
authors.lastname: Duda
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Karl
authors.forename: Tae-Min
authors.initials: TM
authors.lastname: Kim
authors.forename: Avinash R
authors.initials: AR
authors.lastname: Kambadakone
authors.forename: Yen-Lin
authors.initials: YL
authors.lastname: Chen
authors.forename: Courtney
authors.initials: C
authors.lastname: Rothrock
authors.forename: Andrew E
authors.initials: AE
authors.lastname: Rosenberg
authors.forename: G Petur
authors.initials: GP
authors.lastname: Nielsen
authors.forename: David G
authors.initials: DG
authors.lastname: Kirsch
authors.forename: Edwin
authors.initials: E
authors.lastname: Choy
authors.forename: David C
authors.initials: DC
authors.lastname: Harmon
authors.forename: Francis J
authors.initials: FJ
authors.lastname: Hornicek
authors.forename: Jonathan
authors.initials: J
authors.lastname: Dreyfuss
authors.forename: Marek
authors.initials: M
authors.lastname: Ancukiewicz
authors.forename: Dushyant V
authors.initials: DV
authors.lastname: Sahani
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Park
authors.forename: Rakesh K
authors.initials: RK
authors.lastname: Jain
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Delaney